Free Newsletter
More questions about by-the-numbers medicine
There's been a lot of talk lately about whether a "by the numbers" approach to disease is really effective. Do low LDL numbers and high HDL numbers really help prevent heart disease? Are a diabetic's blood-glucose numbers a reliable indicator of just how often--and how severe--complications from the disease might be?
At the American Diabetes Association meeting over the weekend, a few new studies cast further doubt on the effects of tight blood-sugar control. In one study, "Accord," a super-aggressive approach to lowering glycated hemoglobin--considered a major risk factor--actually increased the risk of death. Another, "Advance," showed that super-tight blood sugar control didn't help lower risk of heart disease or death than a more typical approach did.
So what now? No need for an aggressive approach in most patients, researchers said. And instead of relying on blood-sugar control to protect from heart disease, diabetics should turn to the usual pharmalogical suspects for cholesterol and high blood pressure for protection. And in a broader sense, just be prepared for more debate on cholesterol, blood sugar, and other numerical markers.
- read the Wall Street Journal Health Blog post
- check out the New York Times piece
Related Articles:
Does HDL help prevent heart disease?
Cholesterol drug delay signals new FDA standards
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: